OCGN Stock Summary and Trading Ideas (Ocugen | NASDAQ:OCGN)

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen trades on the NASDAQ stock market under the symbol OCGN.

As of April 24, 2025, OCGN stock price climbed to $0.74 with 2,039,998 million shares trading.

OCGN has a beta of 1.95, meaning it tends to be more sensitive to market movements. OCGN has a correlation of 0.20 to the broad based SPY ETF.

OCGN has a market cap of $214.67 million. This is considered a Small Cap stock.

Last quarter Ocugen reported $764,000 in Revenue and -$.05 earnings per share. This beat revenue expectation by $464,000 and met earnings estimates .

In the last 3 years, OCGN traded as high as $3.11 and as low as $.35.

The top ETF exchange traded funds that OCGN belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

OCGN has underperformed the market in the last year with a return of -41.0%, while SPY returned +9.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in OCGN shares. However, OCGN has outperformed the market in the last 3 month and 2 week periods, returning -5.5% and +6.3%, while SPY returned -10.1% and -0.4%, respectively. This indicates OCGN has been having a stronger performance recently.

OCGN support price is $.67 and resistance is $.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OCGN shares will trade within this expected range on the day.